Esther A. Koop
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 26, 2025
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 26, 2025
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.
Journal: ESMO open
Published: September 13, 2023
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 24, 2023
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
Journal: BMC medicine
Published: July 21, 2023
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: June 29, 2022
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 30, 2022
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.
Journal: BMJ open
Published: November 16, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026